Volume 54, Issue 6, Pages (June 2011)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Vitamin D for your patients with chronic hepatitis C?
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 59, Issue 6, Pages (December 2013)
m-TOR inhibitors: What role in liver transplantation?
m-TOR inhibitors: What role in liver transplantation?
Pathological roles of purinergic signaling in the liver
Novel insights in the interplay between inflammation and metabolic diseases: A role for the pathogen sensing kinase PKR  Nicolas Marsollier, Pascal Ferré,
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Reactive oxygen species in the normal and acutely injured liver
Obesity, inflammation, and liver cancer
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Thoetchai (Bee) Peeraphatdit, Douglas A. Simonetto, Vijay H. Shah 
NS5A inhibitors in the treatment of hepatitis C
Jean-Charles Nault, Jessica Zucman-Rossi  Journal of Hepatology 
Histamine regulation of biliary proliferation
Living donor liver transplantation: is the hype over?
Volume 40, Issue 3, Pages (March 2004)
Hepatitis C core protein – The “core” of immune deception?
Signalling pathways in alcohol-induced liver inflammation
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Volume 14, Issue 6, Pages (December 2011)
Volume 62, Issue 1, Pages (January 2015)
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 24, Issue 1, Pages (July 2016)
Autophagy in the liver Journal of Hepatology
Emina Halilbasic, Thierry Claudel, Michael Trauner 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 57, Issue 5, Pages (November 2012)
Another Shp on the Horizon for Bile Acids
Vitamin D for your patients with chronic hepatitis C?
Mona Malz, Federico Pinna, Peter Schirmacher, Kai Breuhahn 
Met as a therapeutic target in HCC: Facts and hopes
Marcel Klingenberg, Akiko Matsuda, Sven Diederichs, Tushar Patel 
Volume 57, Issue 5, Pages (November 2012)
Cédric Coulouarn, Bruno Clément  Journal of Hepatology 
Volume 62, Issue 6, Pages (June 2015)
Volume 42, Issue 6, Pages (June 2005)
Fei Xiao, Jane A. McKeating, Thomas F. Baumert  Journal of Hepatology 
Paul C. Adams, James C. Barton  Journal of Hepatology 
miR-122 – A key factor and therapeutic target in liver disease
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Volume 64, Issue 6, Pages (June 2016)
Innate immunity and HCV
Volume 63, Issue 1, Pages (July 2015)
Epigenetic modifications as new targets for liver disease therapies
m-TOR inhibitors: What role in liver transplantation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Volume 60, Issue 6, Pages (June 2014)
Pathogenesis of cholestatic hepatitis C
Inflammatory pathways in alcoholic steatohepatitis
Chimeric mouse model of hepatitis B virus infection
A 360-degree overview of paediatric NAFLD: Recent insights
Genetics of hepatocellular carcinoma: The next generation
Nuclear receptor regulation of hepatic function
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Volume 62, Issue 6, Pages (June 2015)
Raffaele Teperino, Kristina Schoonjans, Johan Auwerx  Cell Metabolism 
Thierry Gustot, Rajiv Jalan  Journal of Hepatology 
Volume 60, Issue 6, Pages (June 2014)
Presentation transcript:

Volume 54, Issue 6, Pages 1263-1272 (June 2011) The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation  Thijs W.H. Pols, Lilia G. Noriega, Mitsunori Nomura, Johan Auwerx, Kristina Schoonjans  Journal of Hepatology  Volume 54, Issue 6, Pages 1263-1272 (June 2011) DOI: 10.1016/j.jhep.2010.12.004 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Simplified overview of classical bile acid synthesis pathway in mice. CYP7A1 and CYP8B1 catalyze the first and third reaction, respectively. Dotted lines represent several steps in the synthesis of BAs that involve multiple enzymes. AKR1D1 is an abbreviation for Δ4-3-oxosteroid 5β-reductase. Journal of Hepatology 2011 54, 1263-1272DOI: (10.1016/j.jhep.2010.12.004) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Representation of signaling pathways that are modulated by BAs. Genomic and non-genomic actions of BAs are mediated by nuclear receptors and G-protein coupled receptors. The BAs that modulate the activity of the receptor are indicated in the arrow, and are sorted by decreasing potency (top to bottom). Arrows in green indicate agonistic actions, red indicates antagonistic/inhibitory actions and blue indicates a modulatory effect, either agonistic or antagonistic. Receptors for which only a limited number of BAs were tested are indicated with dashed arrows. ∗Only conjugated forms of LCA and DCA are reported to activate the muscarinic receptors. Journal of Hepatology 2011 54, 1263-1272DOI: (10.1016/j.jhep.2010.12.004) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Simplified overview of the TGR5-signaling pathway leading to downstream signaling via cAMP induction. Journal of Hepatology 2011 54, 1263-1272DOI: (10.1016/j.jhep.2010.12.004) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1263-1272DOI: (10. 1016/j. jhep. 2010 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1263-1272DOI: (10. 1016/j. jhep. 2010 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2011 54, 1263-1272DOI: (10. 1016/j. jhep. 2010 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions